MiRNAs and biomarkers in testicular germ cell tumors: An update

28Citations
Citations of this article
38Readers
Mendeley users who have this article in their library.

Abstract

Testicular germ cell tumors (TGCTs) are the leading form of solid cancer and death affecting males between the ages of 20 and 40. Today, their surgical resection and chemotherapy are the treatments of first choice, even if sometimes this is not enough to save the lives of patients with TGCT. As seen for several tumors, the deregulation of microRNAs (miRNAs) is also a key feature in TGCTs. miRNAs are small molecules of RNA with biological activity that are released into biological fluids by testicular cancer cells. Their presence, therefore, can be detected and monitored by considering miRNAs as diagnostic and prognostic markers for TGCTs. The purpose of this review is to collect all the studies executed on miRNAs that have a potential role as biomarkers for testicular tumors.

Cite

CITATION STYLE

APA

De Martino, M., Chieffi, P., & Esposito, F. (2021, February 2). MiRNAs and biomarkers in testicular germ cell tumors: An update. International Journal of Molecular Sciences. MDPI AG. https://doi.org/10.3390/ijms22031380

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free